Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.R. Hernández, A. Pascual, R. Cantón, L. Martínez-Martínez, Grupo de Estudio Infección Hospitalaria (GEIH)a.
Escherichia coli y Klebsiella pneumoniae productores de betalactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000).
Enferm Infecc Microbiol Clin, 21 (2003), pp. 77-82
[2.]
J. Bermejo, P. Lesnaberes, N. Arnesi, M. Gianello, R. Notario, N. Borda, et al.
Factores de riesgo asociados con las infecciones debidas a Klebsiella pneumoniae resistentes a ceftacidima.
Enferm Infecc Microbiol Clin, 21 (2003), pp. 72-76
[3.]
K. Bush, G.A. Jacoby, A.A. Medeiros.
A functional classification scheme for β-lactamases and its correlation with molecular structure.
Antimicrob Agents Chemother, 39 (1995), pp. 1211-1233
[4.]
P.L. Winokur, R. Cantón, J.M. Casellas, N. Legakis.
Variations in the prevalence of strains expressing an extended-spectrum β -lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region.
Clin Infect Dis, 32 (2001), pp. S94-103
[5.]
M. Yuan, H. Aucken, L.M.C. Hall, T.L. Pitt, D.M. Livermore.
Epidemiological typing of klebsiellae with extended-spectrum β-lactamases from European intensive care units.
J Antimicrob Chemother, 41 (1998), pp. 527-539
[6.]
C. Peña, M. Pujol, C. Ardanuy, A. Ricard, R. Pallarés, J. Liñares, et al.
Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases.
Antimicrob Agents Chemother, 42 (1998), pp. 53-58
[7.]
J. Wiener, J.P. Quinn, P.A. Bradford, R.V. Goering, C. Nathan, K. Bush, et al.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
JAMA, 281 (1999), pp. 517-523
[8.]
M. Gniadkouwski.
Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms.
Clin Microbiol Infect, 7 (2001), pp. 597-608
[9.]
D.L. Paterson, W.C. Ko, A. Von Gottberg, J.M. Casellas, L. Mulazimoglu, K.P. Klugman, et al.
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory.
J Clin Microbiol, 39 (2001), pp. 2206-2212
[10.]
A. Wong-Beringer, J. Hindler, M. Loeloff, A.M. Weenan, N. Lee, D.A. Pegues, et al.
Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
Clin Infect Dis, 34 (2002), pp. 135-146
[11.]
National Committee for Clinical Laboratory Standards.
Performance standards for antimicrobial susceptibility testing.
National Committee for Clinical Laboratory Standards, (2002),
[12.]
K.S. Meyer, C. Urban, J.A. Eagan, B.J. Berger, J.J. Rahal.
Nosocomial outbreak of Klebsiella infections resistant to late-generation cephalosporins.
Ann Intern Med, 119 (1993), pp. 353-358
[13.]
A. Asensio, A. Oliver, P. González-Diego, F. Baquero, J.C. Pérez-Díaz, P. Ros, et al.
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as a risk factor for colonization and infection.
Clin Infect Dis, 30 (2000), pp. 55-60
[14.]
E. Lautenbach, J.B. Patel, W.B. Bilker, P.H. Edelstein, N.O. Fishman.
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes.
Clin Infect Dis, 32 (2001), pp. 1162-1171
[15.]
Y.K. Kim, H. Pai, H.J. Lee, S.E. Park, E.H. Choi, J. Kim, et al.
Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome.
Antimicrob Agents Chemother, 46 (2002), pp. 1481-1491
[16.]
C. Peña, M. Pujol, C. Ardanuy, A. Ricart, R. Pallarés, J. Liñares, et al.
An outbreak of hospital-acquired Klebsiella pneumoniae bacteremia, including strains producing extended-spectrum β-lactamase.
J Hosp Infect, 47 (2001), pp. 53-59
[17.]
T. Spanu, F. Luzzaro, M. Perilli, G. Amicosante, A. Toniolo, G. Fadda, The Italian ESBL Study Group, et al.
Occurrence of extended-spectrum β-lactamases in members of the family enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs.
Antimicrob Agents Chemother, 46 (2002), pp. 196-202
[18.]
D.M. Johnson, D.J. Biedenbach, R.N. Jones.
Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): Emphasis on its activity against resistant organisms populations and generally untested species causing community-acquired respiratory tract infections.
Diagn Microbiol Infect Dis, 43 (2002), pp. 49-60
[19.]
D.L. Paterson, Mulazimoglu, J.M. Casellas, W.C. Ko, H. Goossens, A.V. Gottberg, et al.
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β -lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
Clin Infect Dis, 30 (2000), pp. 473-478
[20.]
M. Ahmad, C. Urban, N. Mariano, P.A. Bradford, E. Calcagni, S.J. Projan, et al.
Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.
Clin Infect Dis, 29 (1999), pp. 352-355
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
